Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Genesis DNA

Out of Business LATEST DEAL TYPE

Developer of a genome technology intended to make gene synthesis rapid, inexpensive, and sequence invariant. The company develops a technology that helps to convert digital text into physical DNA, thereby circumventing the cost, turnaround time, and sequence limiting factors of existing synthesis methods.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Primary Office
  • Cambridge, MA
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Genesis DNA’s full profile, request a free trial.

Genesis DNA Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-May-2017 00000 Completed Out of Business
4. Early Stage VC 00000 Completed Startup
3. Accelerator/Incubator 01-Jan-2016 00000 Completed Startup
2. Accelerator/Incubator 12-Sep-2015 $20K $250K Completed Startup
1. Accelerator/Incubator 10-Sep-2015 $250K $250K 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »